青少年血管性血友病并发自发性血胸 1 例并文献复习
Spontaneous pyohaemothorax in a teenager with von Willebrand disease: a case report and review of literature.
机构信息
Pediatrics, University of Kentucky, Lexington, Kentucky, USA
Pediatrics, University of Kentucky, Lexington, Kentucky, USA.
出版信息
BMJ Case Rep. 2021 Aug 17;14(8):e241613. doi: 10.1136/bcr-2021-241613.
Abstract
An 18-year-old man with a history of type 3 von Willebrand disease (VWD) presented with a spontaneous pyohaemothorax. Type 3 VWD may present with both mucocutaneous and deep-seated bleeds, such as visceral haemorrhages, intracranial bleeds and haemarthrosis. There have been very few cases described in children of spontaneous pyohaemothorax. Management of this patient was challenging due to risks of bleeding following surgical drainage, requiring constant replacement with von Willebrand factor concentrate, while monitoring factor VIII levels to balance the risks of thrombosis.
摘要
一名 18 岁男性，患有 3 型血管性血友病（VWD），出现自发性血胸。3 型 VWD 可能表现为黏膜皮肤和深部出血，如内脏出血、颅内出血和关节积血。在儿童中，自发性血胸的病例非常少见。由于手术引流后出血的风险，该患者的治疗极具挑战性，需要持续输注血管性血友病因子浓缩物进行替代治疗，同时监测 VIII 因子水平以平衡血栓形成的风险。
相似文献
1
Spontaneous pyohaemothorax in a teenager with von Willebrand disease: a case report and review of literature.青少年血管性血友病并发自发性血胸 1 例并文献复习
BMJ Case Rep. 2021 Aug 17;14(8):e241613. doi: 10.1136/bcr-2021-241613.
2
Clinical Efficacy and Safety of Fanhdi, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study.《西班牙应用血浆源性 vWF/FVIII 浓缩物凡迪治疗血管性血友病的临床疗效和安全性：一项回顾性研究》。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221074348. doi: 10.1177/10760296221074348.
3
Von Willebrand's disease: case report and review of literature.血管性血友病：病例报告及文献综述
Pan Afr Med J. 2017 Jun 29;27:147. doi: 10.11604/pamj.2017.27.147.12248. eCollection 2017.
4
Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.血管性血友病急性出血的治疗与预防——新一代血管性血友病因子/凝血因子VIII浓缩物Wilate的疗效与安全性
Haemophilia. 2009 Jan;15(1):122-30. doi: 10.1111/j.1365-2516.2008.01901.x.
5
Clinical experience of prophylactic treatment in von Willebrand disease.血管性血友病预防性治疗的临床经验
Thromb Res. 2006;118 Suppl 1:S9-11. doi: 10.1016/j.thromres.2006.01.021. Epub 2006 Apr 17.
6
Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study.高纯度、双重病毒灭活的凝血因子VIII/血管性血友病因子浓缩物（凡迪）治疗血管性血友病的临床疗效：一项回顾性临床研究
Haemophilia. 2002 Nov;8(6):761-7. doi: 10.1046/j.1365-2516.2002.00688.x.
7
Clinical diagnosis of von Willebrand disease.血管性血友病的临床诊断
Haemophilia. 2004 Oct;10 Suppl 4:169-76. doi: 10.1111/j.1365-2516.2004.00991.x.
8
Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literature.艾美赛珠单抗治疗存在或不存在抗血管性血友病因子（VWF）抗体的血管性血友病（VWD）患者的疗效：两例报告及文献复习。
Haemophilia. 2022 Mar;28(2):286-291. doi: 10.1111/hae.14491. Epub 2022 Jan 10.
9
Severe Traumatic Brain Injury in a Patient with von Willebrand Disease Type 2A Successfully Treated with Factor VIII/von Willebrand Factor Concentrates: A Case Report.2A 型血管性血友病患者伴重型颅脑创伤，采用凝血因子 VIII/von Willebrand 因子浓缩物治疗成功：病例报告。
Am J Case Rep. 2022 Aug 30;23:e936690. doi: 10.12659/AJCR.936690.
10
Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.血管性血友病患者的关节出血对生活质量和关节完整性有重大影响：一项横断面研究。
Haemophilia. 2015 May;21(3):e185-e192. doi: 10.1111/hae.12670. Epub 2015 Apr 9.
本文引用的文献
1
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.美国血液学会（ASH）、国际血栓与止血学会（ISTH）、美国国家血友病基金会（NHF）、世界血友病联盟（WFH）2021年血管性血友病管理指南
Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/bloodadvances.2020003264.
2
Von Willebrand's Disease.血管性血友病
N Engl J Med. 2016 Nov 24;375(21):2067-2080. doi: 10.1056/NEJMra1601561.
3
Etiology and management of spontaneous haemothorax.自发性血胸的病因及处理
J Thorac Dis. 2015 Mar;7(3):520-6. doi: 10.3978/j.issn.2072-1439.2014.12.50.
4
Elevated factor VIII levels and risk of venous thrombosis.VIII 因子水平升高与静脉血栓风险。
Br J Haematol. 2012 Jun;157(6):653-63. doi: 10.1111/j.1365-2141.2012.09134.x. Epub 2012 Apr 25.
5
Haemothorax in children with congenital coagulopathy.
Haemophilia. 2010 Jul 1;16(4):688-91. doi: 10.1111/j.1365-2516.2010.02209.x. Epub 2010 Apr 7.
6
The prevalence of symptomatic von Willebrand disease in primary care practice.基层医疗实践中症状性血管性血友病的患病率。
J Thromb Haemost. 2010 Jan;8(1):213-6. doi: 10.1111/j.1538-7836.2009.03661.x. Epub 2009 Oct 23.
7
Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.血管性血友病的临床与实验室诊断：2008年美国国立心肺血液研究所/美国国立卫生研究院指南概要
Am J Hematol. 2009 Jun;84(6):366-70. doi: 10.1002/ajh.21405.
8
12-year experience of spontaneous hemopneumothorax.自发性血气胸的12年经验
Ann Thorac Cardiovasc Surg. 2008 Jun;14(3):149-53.
9
Coagulation disorders.凝血障碍。
Pediatr Rev. 2003 Mar;24(3):83-91. doi: 10.1542/pir.24-3-83.
10
Spontaneous haemothorax: an uncommon presentation of Glanzmann thrombasthenia.自发性血胸：Glanzmann血小板无力症的一种罕见表现。
Acta Paediatr. 2002;91(10):1139-40. doi: 10.1080/080352502760311683.
Zotero 插件